D. E. Shaw & Co., Inc. Insmed Inc Call Options Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding INSM
# of Institutions
447Shares Held
170MCall Options Held
5.79MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA16MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.06 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$908 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA5.87MShares$438 Million0.08% of portfolio
-
State Street Corp Boston, MA4.66MShares$348 Million0.01% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.1B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...